NYSE: IQV
IQVIA Holdings Inc.
Healthcare · Medical - Diagnostics & Research
After hours: $227.30(-0.39%) · as of 7:51 PM ET
Market Cap
$37.56B
52w High
$251.36
52w Low
$154.50
P/E
27.98
Volume
1.05M
Outstanding Shares
164.60M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 24.87% over the last year. Revenue grew 8.17% over the trailing twelve months. Operating margin moved from 13.87% to 13.57%. Free cash flow grew 30% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 13th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 13.57%. Revenue grew 8.17% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
37
Buy
7
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 27, 2026
Q4 FY26 · EPS est $3.27 · Revenue est $4.36B
View